Representation of Patients with Obesity in Atrial Fibrillation Ablation Trials: A Systematic Review
Danielle Dircks,Ahmad Aroudaky,Ei,Muaaz Almerstani,Radha Kanneganti Perue,James Aguto,Jmaylia Mimms,Chenyang Jiang,Lluı́s Mont,Domenico Grieco,Carina Blomström‐Lundqvist,K. V. Davtyan,Sandeep Prabhu,P. Kistler,Arash Aryana,Jason G. Andrade,Laurent Macle,J. William Schleifer,Jason Payne,Arthur R. Easley,Faris Khan,John R. Windle,Shane Tsai,Daniel R. Anderson,Gleb Haynatzki,Thoetchai Peeraphatdit,Niyada Naksuk
DOI: https://doi.org/10.2139/ssrn.4464625
2023-01-01
Abstract:Background: The prevalence and the impact of obesity on outcomes of atrial fibrillation (AF) ablation randomized controlled trials (RCTs) have not been well studied. Objective: To examine the proportion of participants with obesity enrolled in AF RCTs and outcomes of AF ablation when subgroup analysis of participants with obesity were available. Methods: We systematically searched PubMed and EMBASE for AF ablation RCTs published between 01/01/2015 to 05/31/2022. When body mass index (BMI) data were available, normal distribution was assumed and a z-score was used to estimate the proportion of obesity. Results categorized by BMI or body weight status were reviewed. Authors were contacted for additional information. Results: Of 148 eligible RCTs with 30,174 participants, 141 (95.27%) RCTs did not report the proportion of participants with obesity, while published information regarding BMI was available in 63.51%. Three trials excluded patients based on BMI. Using reported BMI, we estimated the proportion of participants with obesity varied greatly across these trials, ranging from 5.82%-71.9% (median 38.02%, interquartile 29.64%, 49.10%). Patients with obesity were represented in a greater proportion among trials conducted in North America (50.23%) and Asia (44.72%), compared to others (32.16%), P<0.001. Subgroup analysis or analysis adjusting for BMI was reported in only 13 (8.78%) RCTs; 4 (30.77%) of these suggested that BMI or body weight might negatively affect primary outcomes. Conclusion: Obesity is a common comorbidity among AF patients. However, most AF ablation RCTs underreported the proportion of participants with obesity and its impact on the main outcomes.